Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer

We have evaluated the efficiency of electrochemotherapy with cisplatin on cutaneous tumor lesions of breast cancer and have compared its efficiency with the efficiency of intratumoral (i.t.) administration of cisplatin alone. The study was performed on six breast cancer patients with 26 cutaneous lesions in whom all standard treatment modalities were exhausted. Of 26 lesions, 12 were treated by electrochemotherapy, six by i.t. cisplatin application, while eight were controls. In all 12 lesions treated by electrochemotherapy and followed-up for up to 26 weeks at the most, the objective response was obtained [complete response in 33% with mean duration of 10 weeks and partial response (PR) in 67% with a mean duration of 5 weeks]. In six lesions treated with i.t. application of cisplatin and followed-up for up to 12 weeks at the most, objective response was obtained in 83% of lesions; none of these responses were complete, the mean duration of PR was 5 weeks. During electrochemotherapy, only minimal local side-effects were observed, whereas no systemic side-effects of the treatment were noticed. We conclude that electrochemotherapy with i.t. cisplatin application is effective in local treatment of cutaneous tumor lesions of breast cancer.

[1]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  M. Rols,et al.  Electrochemotherapy of cutaneous metastases in malignant melanoma , 2000, Melanoma research.

[3]  Gregor Sersa,et al.  Electrochemotherapy: advantages and drawbacks in treatment of cancer patients , 2003 .

[4]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[5]  W. Panje,et al.  Electroporation Therapy of Head and Neck Cancer , 1998, Annals of Otology, Rhinology and Laryngology.

[6]  L. Mir,et al.  The basis of electrochemotherapy. , 2000, Methods in molecular medicine.

[7]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[8]  Gregor Serša,et al.  Electrochemotherapy with Bleomycin in the Treatment of Hypernephroma Metastasis: Case Report and Literature Review , 2000, Tumori.

[9]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases , 2000, Melanoma research.

[10]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[11]  J. Gehl,et al.  Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy , 2000, Melanoma research.

[12]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. , 1998, European journal of cancer.

[13]  S. Rodriguez-Cuevas,et al.  Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. , 2001, Archives of medical research.